Product

CJC-1295 NO DAC Peptide | CJC 1295 NO DAC 5mg

CJC-1295 No DAC, a synthesized research peptide with short-acting properties for growth hormone release is commonly used in laboratories. This variant, unlike the DAC modified version, is intended for shorter activity window, which makes it a common subject of controlled research protocols.

CJC-1295 NO DAC Peptide Specifications

PropertyValue
NameCJC-1295 NO DAC
CAS Number863288-34-0
Peptide SequenceH-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
Molecular FormulaC152H252N44O42
Molecular Weight3367.9 g/mol
PubChem CID488284402
SynonymsCJC-1295 without DAC, CJC-1295 no DAC, Mod GRF(1-29), Modified GRF 1-29, Tetrasubstituted GRF(1-29), GRF(1-29) Analog
Vial SizeCJC-1295 NO DAC 5mg
Purity (HPLC)≥99.0%

CJC-1295 NO DAC Key Features

  • Stringent Research-Use Designation: Created and sold solely for research laboratory testing, in vitro testing, and scholastic study approaches.
  • Lyophilized Peptide Layout: Provided as a secure, freeze-dried cake to preserve molecular stability and decrease degradation prior to reconstitution.
  • Structural Alternative: Lacks the Medication Fondness Complex (DAC), enabling scientists to observe the natural organic half-life of the core peptide sequence.
  • High Chemical Purity: Manufactured utilizing stringent high-performance fluid chromatography (HPLC) and mass spectrometry evaluation to ensure regular assay standards.
  • Standardized Laboratory Handling: Requires accurate reconstitution with bacteriostatic or sterile water within regulated research laboratory atmospheres.
  • Maximized Storage Space Recommendations: Needs details sub-zero temperature control to maintain lasting peptide bond stability.

CJC-1295 NO DAC Overview

The research study of mobile signaling and endocrine pathways depends greatly on architectural analogs that mimic endogenous signaling molecules. CJC-1295 Without DAC stands for a popular compound within life science study, especially classified as a synthetic GHRH analog. By truncating and changing the indigenous GHRH series, researchers developed a 29-amino acid chain that retains certain receptor fondness while removing aspects that alter its natural metabolic clearance price.

In laboratory research contexts, this peptide acts as a criteria for assessing competitive enmity, receptor binding affinities, and downstream additional carrier cascades. Since it does not consist of the maintaining Drug Affinity Complicated, it uses a precise look at the innate residential or commercial properties of the changed peptide sequence itself. Scientists utilize this substance to map out details mobile feedbacks over abbreviated time horizons, making it a necessary asset for relative biochemistry and architectural biology researches.

What is CJC-1295 NO DAC?

To understand the utility of Study Use CJC-1295 NO DAC, it is necessary to analyze its chemical advancement. The compound is a tetrasubstituted analog of Sermonorelin, which itself is a functional fragment of endogenous Growth Hormone-Releasing Hormone. The modifications at placements 2, 8, 15, and 27 of the amino acid chain are made to boost resistance versus chemical bosom by dipeptidyl peptidase-4 (DPP-4) artificial insemination.

The main distinction in peptide nomenclature lies between the DAC (Drug Fondness Complex) and NO DAC variants:

  • CJC-1295 DAC: Attributes an included biotinylated lysine linker connected to a maleimide group, allowing the peptide to bind covalently to albumin, expanding its existence in a test system.
  • CJC-1295 NO DAC: Lacks this facility, meaning the peptide communicates with target receptors based exclusively on its core 29-amino acid affinity, resulting in a dramatically much shorter half-life within speculative designs.

This architectural lack permits researchers to do pulse-chase assays and short-duration kinetics researches without the intensifying variable of long-lasting albumin binding.

CJC-1295 NO DAC in Scientific Research

In contemporary lab investigations, CJC-1295 NO DAC is mainly released in speculative peptide research studies focusing on axis policy and mobile feedback loops. Due to the fact that the peptide serves as a discerning agonist of the GHRH receptor, it is used to study the depolarization of somatotropic cell membrane layers and the subsequent activation of adenylate cyclase.

Research approaches involving this peptide generally focus on:

  1. Receptor Downregulation: Observing just how continuous versus pulsatile exposure to GHRH analogs alters receptor sensitivity in separated tissue societies.
  2. Intracellular Signaling: Determining cyclic adenosine monophosphate (cAMP) build-up complying with intro of the peptide to cellular mediums.
  3. Relative Assays: Benchmarking the signaling effectiveness of tetrasubstituted peptides versus wild-type endogenous hormonal agents.

Keeping rigorous environmental criteria throughout these experimental styles is critical, as structural shifts in the peptide can change binding accounts and alter standard data.

CJC-1295 NO DAC vs. CJC-1295 DAC

Scientific ParameterCJC-1295 NO DACCJC-1295 DAC
Chemical Structure29-amino acid core chain (Tetrasubstituted)29-amino acid core + Drug Affinity Complex (Maleimide)
Albumin AffinityNon-binding / NegligibleHigh covalent binding affinity
Experimental Half-LifeShort / Minutes to hours in solutionExtended / Multiple days in test models
Primary Research FocusPulsatile dynamics and immediate receptor kineticsSustained exposure and long-term metabolic pathway tracking
Laboratory StabilityRequires prompt utilization post-reconstitutionHigher tolerance to long-term incubation
Storage RequirementsLong-term at -20°C to -80°C (Lyophilized)Long-term at -20°C to -80°C (Lyophilized)

Storage and Handling Guidelines

Proper CJC-1295 NO DAC Storage protocols are vital to preserving the secondary structure of the peptide and ensuring reproducible scientific data. Peptides are highly susceptible to hydrolytic degradation, oxidation, and physical shear stress.

Temperature Control

  • Long-Term Storage: Unreconstituted, Lyophilized CJC-1295 NO DAC must be kept at -20°C or lower. For prolonged preservation exceeding six months, storage at -80°C is highly recommended.
  • Short-Term Storage: The sealed vial may be held at 4°C for up to four weeks prior to an active experiment, provided it remains completely desiccated.

Moisture and Light Protection

  • Desiccation: Ambient moisture can cause rapid hydrolysis of freeze-dried peptides. Vials should be brought to room temperature inside a desiccator before opening to prevent condensation from forming on the product.
  • Photolytic Safeguards: Exposure to direct ultraviolet light can destabilize peptide bonds. Store vials in original opaque boxes or dark laboratory environments.

Laboratory Handling Practices

  • Reconstitution Care: Avoid vigorous agitation or vortexing upon adding liquid medium. Gently swirl the vial to encourage dissolution; harsh mechanical force can fracture the delicate tertiary structure of the peptide chain.

Frequently Asked Questions

What is CJC-1295 NO DAC?

It is a synthetic, 29-amino acid peptide that works as a changed analog of Growth Hormone-Releasing Hormone (GHRH). It is developed totally for lab experimentation to research study receptor communications.

What is the distinction in between DAC and NO DAC?

DAC stands for Drug Affinity Complicated. The variation without DAC lacks the maleimide affinity modifier, suggesting it does not bind to albumin and possesses a dramatically shorter functional half-life in lab versions.

Just how should CJC-1295 NO DAC be saved?

Before make use of, the completely dry lyophilized powder needs to be stored in a freezer at -20 ° C to -80 ° C to maximize stability and protect against structural degradation over time.

What does lyophilized peptide mean?

Lyophilization is a specialized suspended animation process that gets rid of water from the substance while it is frozen. This technique stabilizes the peptide’s chemical structure for safer transportation and lasting storage space.

Why exist alterations on the amino acid chain?

The tetrasubstitution on the core sequence safeguards the compound from fast enzymatic degradation by particles like DPP-4 during artificial insemination assay testing, enabling more clear monitoring of target signaling pathways.

Can this product be saved at room temperature level?

Just for short durations during transit. Extended exposure to space temperature level presents the threat of accelerated peptide destruction and reduction in pureness levels.

How is the purity of the peptide verified?

Pureness is verified via common laboratory logical chemistry practices, significantly High-Performance Fluid Chromatography (HPLC) and Mass Spectrometry (MS) evaluation.

Research Notes

Research laboratory Notice: This item account offers exclusively as an instructional blueprint and chemical spec sheet. All materials listed are meant for specialized lab settings by experienced scientific workers. They are not meant to sustain insurance claims of physical performance, scientific treatments, or organic optimization.

Scientific References

  1. Peer-Reviewed Journals: Journal of Clinical Endocrinology and Metabolism, International Journal of Peptide Research and Therapeutics, and European Journal of Pharmacology.
  2. Research Institutions: Studies on GHRH analogs cataloged via the National Institutes of Health (NIH) and PubMed databases.
  3. Scientific Databases: PubChem Compound Database (CID reference matching tetrasubstituted GHRH structural variants).

Get a Quick Quote

Name

⚠ Intended Use

All products are intended for in vitro laboratory research use only.
They are strictly prohibited for administration to humans or animals, and must not be used for diagnostic, therapeutic, or clinical applications.

Storage and Handling

Store lyophilized powder at –20°C.
After reconstitution (for laboratory analysis), store at 2–8°C.
Avoid repeated freeze-thaw cycles.
Maintain aseptic technique during handling.

Submit your requirements

Name